ROST, GL, AVGO, GLW and STZ emerge as defensive plays as Iran war tensions lift oil prices and rattle markets, spotlighting cash-efficient stocks.

USA Financial Formulas reduced its position in shares of Globe Life Inc. (NYSE: GL) by 89.6% during the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 606 shares of the company's stock after selling 5,237 shares during the period.

GL is set to grow on growing premiums, rising investment income and disciplined capital deployment.

Globe Life Inc. (NYSE: GL - Get Free Report) has been assigned an average rating of "Moderate Buy" from the eleven research firms that are covering the stock, Marketbeat reports. Two research analysts have rated the stock with a hold recommendation, eight have given a buy recommendation and one has given a strong buy recommendation to

ROST, GL, AVGO, CL and TEL emerge as top bets as oil volatility shakes markets, spotlighting cash-rich firms built to deliver stronger returns.

Globe Life offers a compelling long-term dividend growth profile, despite its modest 0.8% yield, making it ideal for future-focused portfolios. GL's affordable, sticky policies drive recurring revenue and organic growth, supported by a large underinsured market and expanding exclusive agent force. Trading at a 17% discount to a $171 fair value estimate, GL's forward P/E of 9.2 is well below historical averages, positioning it for potential revaluation.

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.

Globe Life Inc. (NYSE: GL - Get Free Report) CEO James Matthew Darden sold 18,318 shares of the company's stock in a transaction that occurred on Wednesday, March 4th. The stock was sold at an average price of $145.10, for a total value of $2,657,941.80. Following the completion of the sale, the chief executive officer owned

Globe Life (GL) reported earnings 30 days ago. What's next for the stock?

Flowserve, Methanex and Globe Life stand out as sales-growth picks as investors face geopolitical and AI-related headwinds.